Connect Biopharma Files 8-K
Ticker: CNTB · Form: 8-K · Filed: May 13, 2025 · CIK: 1835268
Sentiment: neutral
Topics: regulatory-filing, disclosure
Related Tickers: CNTB
TL;DR
CNTB filed an 8-K, likely with new info. Check it.
AI Summary
Connect Biopharma Holdings Ltd. filed an 8-K on May 13, 2025, to report on other events and a Regulation FD disclosure. The filing does not contain specific details about the nature of these events or disclosures within the provided text.
Why It Matters
This filing indicates that Connect Biopharma Holdings Ltd. has made a regulatory disclosure, which could contain material information for investors.
Risk Assessment
Risk Level: medium — An 8-K filing often contains material information that can impact a company's stock price, but the specific content is not detailed here.
Key Numbers
- 001-40212 — SEC File Number (Identifies the company's filings with the SEC.)
Key Players & Entities
- Connect Biopharma Holdings Ltd (company) — Registrant
- May 13, 2025 (date) — Date of earliest event reported
- 001-40212 (other) — SEC File Number
- 3580 Carmel Mountain Road, Suite 200 (address) — Principal Executive Offices
- San Diego, California (location) — Principal Executive Offices
FAQ
What specific events are being disclosed in this 8-K filing?
The provided text does not specify the exact events being disclosed, only that the filing is for 'Other Events' and 'Regulation FD Disclosure'.
What is the primary purpose of this 8-K filing for Connect Biopharma Holdings Ltd?
The primary purpose is to report on 'Other Events' and 'Regulation FD Disclosure' as of May 13, 2025.
When was this 8-K filing submitted?
The filing was submitted on May 13, 2025.
What is the company's principal executive office address?
The company's principal executive office is located at 3580 Carmel Mountain Road, Suite 200, San Diego, California, 92130.
What is the SEC file number for Connect Biopharma Holdings Ltd?
The SEC file number for Connect Biopharma Holdings Ltd is 001-40212.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding Connect Biopharma Holdings Ltd (CNTB).